Literature DB >> 22310962

Copy number variations on chromosome 4q26-27 are associated with Cantu syndrome.

Mazen Kurban1, Chong Ae Kim, Maija Kiuru, Katherine Fantauzzo, Rita Cabral, Ossama Abbas, Brynn Levy, Angela M Christiano.   

Abstract

BACKGROUND: Cantu syndrome is a rare condition which is characterized clinically by hypertrichosis, cardiomegaly and bone abnormalities. Inherited hypertrichoses are very rare human disorders whose incidence has been estimated as low as 1 in 1 billion. The genetic basis of hypertrichosis is largely unknown, and currently no single gene has been directly implicated in its pathogenesis, although position effects have been reported.
METHODS: We analyzed the DNA of a patient with Cantu syndrome on the Affymetrix Cytogenetics Whole-Genome 2.7M array for copy number variations (CNVs). We then performed genomic copy number quantification using qPCR, and finally we performed gene expression analysis in the hair follicle for the genes lying within and around the region of the duplication.
RESULTS: We identified a 375 kb duplication on chromosome 4q26-27. The duplication region encompassed three genes, which included MYOZ2, USP53 and FABP2. MYOZ2 and USP53 are known to be highly expressed in the cardiac muscle, and we found that USP53 is expressed in the hair follicle.
CONCLUSION: We propose that CNVs involving chromosome 4q26-27 may be associated with Cantu syndrome. CNVs spanning several genes may help define the molecular basis of syndromes which have unrelated clinical features.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22310962      PMCID: PMC3696378          DOI: 10.1159/000333800

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  22 in total

Review 1.  Autosomal dominant inheritance in Cantú syndrome (congenital hypertrichosis, osteochondrodysplasia, and cardiomegaly).

Authors:  B Lazalde; R Sánchez-Urbina; I Nuño-Arana; W E Bitar; M de Lourdes Ramírez-Dueñas
Journal:  Am J Med Genet       Date:  2000-10-23

Review 2.  Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease.

Authors:  Anne S Bassett; Stephen W Scherer; Linda M Brzustowicz
Journal:  Am J Psychiatry       Date:  2010-05-03       Impact factor: 18.112

3.  Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins.

Authors:  Norbert Frey; Eric N Olson
Journal:  J Biol Chem       Date:  2002-02-12       Impact factor: 5.157

4.  A new form of hypertrichosis inherited as an X-linked dominant trait.

Authors:  M A Macías-Flores; D García-Cruz; H Rivera; M Escobar-Luján; A Melendrez-Vega; D Rivas-Campos; F Rodríguez-Collazo; I Moreno-Arellano; J M Cantú
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  A distinct osteochondrodysplasia with hypertrichosis- Individualization of a probable autosomal recessive entity.

Authors:  J M Cantú; D García-Cruz; J Sánchez-Corona; A Hernández; Z Nazará
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

6.  An autosomal dominant syndrome of acromegaloid facial appearance and generalised hypertrichosis terminalis.

Authors:  A D Irvine; O M Dolan; D R Hadden; F J Stewart; E A Bingham; N C Nevin
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

7.  A new case of Ambras syndrome associated with a paracentric inversion (8) (q12; q22)

Authors:  R Balducci; V Toscano; B Tedeschi; A Mangiantini; R Toscano; C Galasso; S Cianfarani; B Boscherini
Journal:  Clin Genet       Date:  1998-06       Impact factor: 4.438

Review 8.  Ambras syndrome: delineation of a unique hypertrichosis universalis congenita and association with a balanced pericentric inversion (8) (p11.2; q22)

Authors:  F A Baumeister; J Egger; M T Schildhauer; S Stengel-Rutkowski
Journal:  Clin Genet       Date:  1993-09       Impact factor: 4.438

9.  Cloning of the breakpoints of a de novo inversion of chromosome 8, inv (8)(p11.2q23.1) in a patient with Ambras syndrome.

Authors:  M Tadin-Strapps; D Warburton; F A M Baumeister; S G Fischer; J Yonan; T C Gilliam; A M Christiano
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

Review 10.  Position effect in human genetic disease.

Authors:  D J Kleinjan; V van Heyningen
Journal:  Hum Mol Genet       Date:  1998       Impact factor: 6.150

View more
  4 in total

1.  Cantú syndrome is caused by mutations in ABCC9.

Authors:  Bregje W M van Bon; Christian Gilissen; Dorothy K Grange; Raoul C M Hennekam; Hülya Kayserili; Hartmut Engels; Heiko Reutter; John R Ostergaard; Eva Morava; Konstantinos Tsiakas; Bertrand Isidor; Martine Le Merrer; Metin Eser; Nienke Wieskamp; Petra de Vries; Marloes Steehouwer; Joris A Veltman; Stephen P Robertson; Han G Brunner; Bert B A de Vries; Alexander Hoischen
Journal:  Am J Hum Genet       Date:  2012-05-17       Impact factor: 11.025

2.  Phenotypic Modulation of Smooth Muscle Cells in Atherosclerosis Is Associated With Downregulation of LMOD1, SYNPO2, PDLIM7, PLN, and SYNM.

Authors:  Ljubica Perisic Matic; Urszula Rykaczewska; Anton Razuvaev; Maria Sabater-Lleal; Mariette Lengquist; Clint L Miller; Ida Ericsson; Samuel Röhl; Malin Kronqvist; Silvia Aldi; Joelle Magné; Valentina Paloschi; Mattias Vesterlund; Yuhuang Li; Hong Jin; Maria Gonzalez Diez; Joy Roy; Damiano Baldassarre; Fabrizio Veglia; Steve E Humphries; Ulf de Faire; Elena Tremoli; Jacob Odeberg; Vladana Vukojević; Janne Lehtiö; Lars Maegdefessel; Ewa Ehrenborg; Gabrielle Paulsson-Berne; Göran K Hansson; Jan H N Lindeman; Per Eriksson; Thomas Quertermous; Anders Hamsten; Ulf Hedin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-28       Impact factor: 8.311

3.  Ubiquitin specific peptidase Usp53 regulates osteoblast versus adipocyte lineage commitment.

Authors:  Hadla Hariri; William N Addison; René St-Arnaud
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

4.  Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.

Authors:  Dingwen Gui; Zhufeng Dong; Wei Peng; Weidong Jiang; Geng Huang; Gang Liu; Zhihua Ye; Yang Wang; Zuwei Xu; Jinlun Fu; Shuai Luo; Yunfei Zhao
Journal:  Cancer Med       Date:  2021-05-11       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.